Vomaris Announces First Patient Enrollment in Study on Effects of Bioelectric Wound Care in Hidradenitis Suppurativa

Vomaris Innovations, Inc. announces the first patient enrollment in a study using its bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).   About HSHS is a chronic inflammatory skin condition that affects 1-4% of the global population. It occurs more often in women than men and is characterized by recurring pus-filled […]

Technology Effective Against Antibiotic-Resistant Pathogen

Research shows antibiotic-resistant Candida albicans is killed by exposure to Vomaris Bioelectric V.Dox™ Technology   Vomaris Innovations, Inc. announced today the publication of results demonstrating that the company’s bioelectric V.Dox™ Technology is effective in killing antibiotic-resistant Candida albicans pathogens. The manuscript, “Ketoconazole Resistant Candida albicans is Sensitive to a Wireless Electroceutical Wound Care Dressing,” was published in Bioelectrochemistry […]

Skip to content